No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

David C. Evans to Join BOD at Cardinal Health

Editor: What To Know

  • He also serves on the board of directors for the Siegel Rare Neuroimmune Association and formerly served as a board member on the finance and audit committee for Ohio Health.
  • Evans serves on the board of directors for Scotts MiracleGro and is a member of both the audit committee and the compensation and organization committee.
  • Evans served as Executive Vice President and Chief Financial Officer of The Scotts MiracleGro Company, the leading manufacturer and marketer of branded consumer lawn and garden products in North America.

June 26, 2020

David C. Evans has been elected as an independent director, effective July 1. The news was announced by Cardinal Health.

David C. Evans brings decades of financial expertise and strong, diverse board experiences.

Most recently, David C. Evans served as interim Chief Financial Officer for Cardinal Health for approximately nine months. He previously held the role of Chief Financial Officer of Battelle Memorial Institute, one of the largest private, non-profit research organizations in the world. Prior to that, Mr. Evans served as Executive Vice President and Chief Financial Officer of The Scotts MiracleGro Company, the leading manufacturer and marketer of branded consumer lawn and garden products in North America.

Currently, Mr. Evans serves on the board of directors for Scotts MiracleGro and is a member of both the audit committee and the compensation and organization committee. He also serves on the board of directors for the Siegel Rare Neuroimmune Association and formerly served as a board member on the finance and audit committee for Ohio Health.

“We are pleased to welcome Dave as a director,” said Gregory Kenny, Chairman of the Board for Cardinal Health. “The Board has been impressed by both his operational instincts and his financial acumen. Dave sees both the big picture, as well as the value drivers, while never losing sight of our mission – being essential to care. We look forward to benefitting from his history as a strong and independent-minded leader as we continue to navigate this time of immense change and adapt our growth strategies for the future.”

Mr. Evans holds a Bachelor of Science in Business Administration degree in Accounting from The Ohio State University.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

VeraClinic: Pioneering Personal Transformation Through Hair Transplantation and Cosmetic Surgery in Turkey

As a testament to Turkey's legacy in the world of aesthetic medicine, VeraClinic invites you to discover the transformative power of our hair transplantation and cosmetic surgery services.

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy